Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model

Triple-negative breast cancer (TNBC) is a highly aggressive phenotype that is resistant to standard therapy. Thus, the development of alternative therapeutic strategies for TNBC is essential. The purpose of our in vitro study was to evaluate the impact of p53 gene silencing in conjunction with the a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Braicu, Cornelia, Pileczki, Valentina, Pop, Laura, Petric, Roxana Cojocneanu, Chira, Sergiu, Pointiere, Eve, Achimas-Cadariu, Patriciu, Berindan-Neagoe, Ioana
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4388814/
https://ncbi.nlm.nih.gov/pubmed/25849487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0120936
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados